ALB and liver failure: Intrasplenic or injection of SC-derived hepatocytes to human [45] or animal with liver injury or liver failure increased ALB, AFP, CK-19, and antitripcin mRNA expression, ALB secretion, serum ALB concentration, and reduced bilirubinemia.